Adaptive Biotechnologies Corporation Share Price & Technical Analysis
ADPT · $13.88 (+0.07%)
Healthcare / Diagnostics & Research
$13.88
+0.07%
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-2% return in May, 20% avg return in past 3 year May month.
-11% return in 2026, 44% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 14% | -13% | -10% | 1% | -2% | – | – | – | – | – | – | – | -11% |
| 25 | 28% | 11% | -11% | 1% | 28% | 22% | -11% | 32% | 16% | 17% | 14% | -16% | 132% |
| 24 | -24% | 11% | -22% | -21% | 35% | 3% | 24% | 4% | 11% | -6% | 20% | 2% | 36% |
| 23 | 18% | -8% | 2% | -19% | -3% | -4% | 25% | -19% | -21% | -19% | -2% | 11% | -38% |
| 22 | -38% | -18% | -3% | -41% | -5% | 3% | 14% | -2% | -20% | 8% | 10% | -14% | -107% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.13B
P/E ratio
—
52W high
$20.76
52W low
$8.96
Volume
12,35,006
Beta
2.16
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Adaptive Biotechnologies Corporation share price today?
- Adaptive Biotechnologies Corporation (ADPT) last traded around $13.88 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ADPT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ADPT. Download the app for real-time alerts.
- How can I analyze Adaptive Biotechnologies Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.